TVPW
IDXX icon

Third View Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Third View Private Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$873K Sell
1,658
-150
-8% -$84.1K 0.11% 143
2026
Q1 		$1.02M Buy
1,808
+26
+1% +$16.7K 0.14% 122
2025
Q4 		$1.21M Buy
+1,782
New +$1.21M 0.16% 117

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Third View Private Wealth's IDXX Position: Q2 2026 in Review

Third View Private Wealth reduced its Idexx Laboratories (IDXX) stake by 8.3% in Q2 2026, selling an estimated $84.1K and leaving 1,658 shares worth $873K. The position accounts for 0.11% of the portfolio, ranked #143.

Third View Private Wealth first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.21M in Q4 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Third View Private Wealth held 1,658 shares of Idexx Laboratories worth $873K as of Q2 2026.
  • Third View Private Wealth sold 150 Idexx Laboratories shares in Q2 2026, an estimated $84.1K.
  • Idexx Laboratories made up 0.11% of Third View Private Wealth's portfolio in Q2 2026, its #143 holding.
  • Third View Private Wealth first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Third View Private Wealth's Idexx Laboratories position peaked at $1.21M in Q4 2025.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Third View Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.